Inside the research

Avantor, Inc.

AVTR Research profile · latest available data

Price overview

$15.25

▼ -0.13 (-0.8%)

52w hi$15.86
52w lo$7.41
Vol6.53M
As of25 Sep 2026

The Verdict

Hold

Our score +0.31

Short+0.64
Medium+0.39
Long-0.51

computed 2026-09-27

Key fundamentals

Avantor, Inc.

Healthcare · Medical Instruments & Supplies

Market cap$10.31B
Enterprise value$13.71B
Forward P/E17.30x
EV / EBITDA14.52x
P / S (ttm)1.57x
Profit margin-8.8%
Return on equity-9.7%
Revenue growth+0.5%
Earnings growth-37.4%
Debt / equity65.68

Layer Breakdown

LayerRawContribution
Fundamental-0.14
Sector+0.08
Technical+0.42
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

United States · www.avantorsciences.com

Risk Metrics

Beta vs SPX1.03
Corr SPX0.34
Annual vol48.8%
Annual ret-16.3%
Sharpe-0.33
Max DD-72.1%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$9.92
High / Low$19.00 / $7.00
Median$9.00
Analysts13
Strong Buy0
Buy3
Hold10
Sell1
Strong Sell1

Recent rating actions

2026-04-30Evercore ISI Group→ In-Line
2026-04-30Citigroup→ Neutral
2026-04-15Barclays→ Underweight
2026-04-06Evercore ISI Group→ In-Line
2026-03-06Barclays→ Underweight
2026-02-13Wells Fargo→ Overweight

Material Events

DateEvent8-K
2026-07-29Earnings Release, Exhibitsread
2026-07-17Material Agreement, Material Obligation…read
2026-05-12Shareholder Vote, Exhibitsread
2026-04-29Earnings Release, Exhibitsread
2026-04-23Officer / Director Change, Reg FD Disclosure…read
2026-04-01Officer / Director Change, Reg FD Disclosure…read
2026-02-11Earnings Release, Reg FD Disclosure…read
2025-12-18Officer / Director Change, Reg FD Disclosure…read
2025-12-04Officer / Director Change, Reg FD Disclosure…read
2025-11-10Officer / Director Change, Reg FD Disclosure…read
2025-10-29Earnings Release, Exhibitsread
2025-10-14Material Agreement, Termination of Agreement…read

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders8
Top-5 share98.3%
HHI2,981 (concentrated)

Top Holders

HolderValueShares
State Street Corp$213.57M21.57M
AQR Capital Management$115.11M11.63M
Fidelity / FMR LLC$77.67M7.85M
Capital Research / Capital World$56.16M5.67M
Millennium Management$7.46M753.58K
Citadel Advisors$5.08M512.95K
Bridgewater Associates$2.98M301.22K
T. Rowe Price Group$6.83K689.85K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-044view
2026-07-298-Kview
2026-07-2910-Qview
2026-07-274view
2026-07-178-Kview
2026-06-224view
2026-05-128-Kview
2026-05-114view
2026-05-114view
2026-05-114view
2026-05-114view
2026-05-114view
2026-05-114view
2026-05-114view
2026-05-114view

The Long Run

FY 2019–2025 · 6 years

LineLatestCAGRTrend
Revenue$6.55B+34.2%
Gross profit$2.14B+37.2%
Operating income$696.40M+4.8%
Net income$321.10M+53.4%
Cash from ops$840.80M+18.9%

Indices

S&P MidCap 400

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$15.33$15.36$15.07$15.256.53M
Sep 24$14.72$15.43$14.67$15.387.72M
Sep 23$14.95$15.14$14.72$14.7610.57M
Sep 22$15.13$15.32$14.91$14.9411.16M
Sep 21$15.39$15.59$15.04$15.109.19M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →